ANGELA DEE: Open Payments
NPI 1447925128 · EAST HARTFORD, CT. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,004 in 53 payments from 15 companies in 2025. Trend: 2023 $1,214 · 2024 $2,043 · 2025 $1,004
Food & beverage: $1,004
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 19 | $275 |
| Takeda Pharmaceuticals U.S.A., Inc. | 9 | $206 |
| Janssen Biotech, Inc. | 7 | $159 |
| Ardelyx, Inc. | 4 | $82 |
| Gilead Sciences, Inc. | 3 | $56 |
| Phathom Pharmaceuticals, Inc. | 2 | $32 |
| Madrigal Pharmaceuticals | 1 | $27 |
| Celltrion USA Inc. | 1 | $27 |
| Regeneron Healthcare Solutions, Inc. | 1 | $23 |
| Amgen Inc. | 1 | $23 |
Products named: ENTYVIO, TREMFYA, SKYRIZI, RINVOQ, IBSRELA, DUPIXENT, VOQUEZNA, REZDIFFRA.
Industry payments across CT — which companies pay providers there.
